nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetazolamide—AQP1—gall bladder—pancreatic cancer	0.0367	0.164	CbGeAlD
Acetazolamide—CA9—gall bladder—pancreatic cancer	0.0258	0.115	CbGeAlD
Acetazolamide—AQP1—islet of Langerhans—pancreatic cancer	0.0241	0.107	CbGeAlD
Acetazolamide—AQP1—pancreas—pancreatic cancer	0.0169	0.0754	CbGeAlD
Acetazolamide—CA9—islet of Langerhans—pancreatic cancer	0.0169	0.0753	CbGeAlD
Acetazolamide—AQP1—digestive system—pancreatic cancer	0.0144	0.0644	CbGeAlD
Acetazolamide—CA7—digestive system—pancreatic cancer	0.0115	0.0515	CbGeAlD
Acetazolamide—CA9—digestive system—pancreatic cancer	0.0101	0.0452	CbGeAlD
Acetazolamide—CA2—gall bladder—pancreatic cancer	0.00978	0.0436	CbGeAlD
Acetazolamide—CA5B—pancreas—pancreatic cancer	0.00788	0.0351	CbGeAlD
Acetazolamide—CA4—islet of Langerhans—pancreatic cancer	0.00774	0.0345	CbGeAlD
Acetazolamide—CA12—digestive system—pancreatic cancer	0.0075	0.0335	CbGeAlD
Acetazolamide—CA1—pancreas—pancreatic cancer	0.00696	0.031	CbGeAlD
Acetazolamide—CA2—islet of Langerhans—pancreatic cancer	0.00641	0.0286	CbGeAlD
Acetazolamide—CA1—digestive system—pancreatic cancer	0.00594	0.0265	CbGeAlD
Acetazolamide—CA4—digestive system—pancreatic cancer	0.00464	0.0207	CbGeAlD
Acetazolamide—CA2—pancreas—pancreatic cancer	0.00451	0.0201	CbGeAlD
Acetazolamide—Dysgeusia—Tamoxifen—pancreatic cancer	0.00386	0.005	CcSEcCtD
Acetazolamide—Hypoaesthesia—Sunitinib—pancreatic cancer	0.00386	0.005	CcSEcCtD
Acetazolamide—CA2—digestive system—pancreatic cancer	0.00385	0.0172	CbGeAlD
Acetazolamide—Erythema multiforme—Sunitinib—pancreatic cancer	0.00366	0.00475	CcSEcCtD
Acetazolamide—Glycosuria—Epirubicin—pancreatic cancer	0.00366	0.00474	CcSEcCtD
Acetazolamide—Injection site pain—Epirubicin—pancreatic cancer	0.00363	0.00471	CcSEcCtD
Acetazolamide—Flushing—Sunitinib—pancreatic cancer	0.0036	0.00466	CcSEcCtD
Acetazolamide—Hepatic failure—Docetaxel—pancreatic cancer	0.00355	0.0046	CcSEcCtD
Acetazolamide—Blood disorder—Epirubicin—pancreatic cancer	0.00355	0.0046	CcSEcCtD
Acetazolamide—Leukopenia—Tamoxifen—pancreatic cancer	0.00353	0.00457	CcSEcCtD
Acetazolamide—Photosensitivity reaction—Fluorouracil—pancreatic cancer	0.00349	0.00452	CcSEcCtD
Acetazolamide—Stevens-Johnson syndrome—Gemcitabine—pancreatic cancer	0.00343	0.00445	CcSEcCtD
Acetazolamide—Glycosuria—Doxorubicin—pancreatic cancer	0.00338	0.00439	CcSEcCtD
Acetazolamide—Jaundice cholestatic—Epirubicin—pancreatic cancer	0.00337	0.00437	CcSEcCtD
Acetazolamide—Injection site pain—Doxorubicin—pancreatic cancer	0.00336	0.00436	CcSEcCtD
Acetazolamide—Discomfort—Tamoxifen—pancreatic cancer	0.00331	0.0043	CcSEcCtD
Acetazolamide—Dysgeusia—Sunitinib—pancreatic cancer	0.0033	0.00428	CcSEcCtD
Acetazolamide—Haematuria—Gemcitabine—pancreatic cancer	0.0033	0.00428	CcSEcCtD
Acetazolamide—Blood disorder—Doxorubicin—pancreatic cancer	0.00328	0.00426	CcSEcCtD
Acetazolamide—Hepatobiliary disease—Gemcitabine—pancreatic cancer	0.00328	0.00425	CcSEcCtD
Acetazolamide—Agranulocytosis—Gemcitabine—pancreatic cancer	0.00323	0.00419	CcSEcCtD
Acetazolamide—Hyponatraemia—Docetaxel—pancreatic cancer	0.0032	0.00415	CcSEcCtD
Acetazolamide—Agranulocytosis—Fluorouracil—pancreatic cancer	0.00318	0.00412	CcSEcCtD
Acetazolamide—Thrombocytopenia—Tamoxifen—pancreatic cancer	0.00315	0.00408	CcSEcCtD
Acetazolamide—Shock—Erlotinib—pancreatic cancer	0.00313	0.00406	CcSEcCtD
Acetazolamide—Jaundice cholestatic—Doxorubicin—pancreatic cancer	0.00312	0.00405	CcSEcCtD
Acetazolamide—Thrombocytopenia—Erlotinib—pancreatic cancer	0.00311	0.00404	CcSEcCtD
Acetazolamide—Hypoaesthesia—Fluorouracil—pancreatic cancer	0.00304	0.00394	CcSEcCtD
Acetazolamide—Leukopenia—Sunitinib—pancreatic cancer	0.00302	0.00392	CcSEcCtD
Acetazolamide—Ataxia—Docetaxel—pancreatic cancer	0.003	0.00389	CcSEcCtD
Acetazolamide—Flushing—Irinotecan—pancreatic cancer	0.00296	0.00384	CcSEcCtD
Acetazolamide—Erythema multiforme—Gemcitabine—pancreatic cancer	0.00294	0.00381	CcSEcCtD
Acetazolamide—Convulsion—Sunitinib—pancreatic cancer	0.00292	0.00379	CcSEcCtD
Acetazolamide—Melaena—Epirubicin—pancreatic cancer	0.00289	0.00375	CcSEcCtD
Acetazolamide—Paraesthesia—Tamoxifen—pancreatic cancer	0.00289	0.00374	CcSEcCtD
Acetazolamide—Toxic epidermal necrolysis—Docetaxel—pancreatic cancer	0.00287	0.00372	CcSEcCtD
Acetazolamide—Dyspepsia—Tamoxifen—pancreatic cancer	0.00283	0.00367	CcSEcCtD
Acetazolamide—Dyspepsia—Erlotinib—pancreatic cancer	0.0028	0.00363	CcSEcCtD
Acetazolamide—Decreased appetite—Tamoxifen—pancreatic cancer	0.00279	0.00362	CcSEcCtD
Acetazolamide—Aplastic anaemia—Epirubicin—pancreatic cancer	0.00278	0.00361	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Tamoxifen—pancreatic cancer	0.00277	0.0036	CcSEcCtD
Acetazolamide—Fatigue—Tamoxifen—pancreatic cancer	0.00277	0.00359	CcSEcCtD
Acetazolamide—Decreased appetite—Erlotinib—pancreatic cancer	0.00276	0.00359	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Erlotinib—pancreatic cancer	0.00275	0.00356	CcSEcCtD
Acetazolamide—Fatigue—Erlotinib—pancreatic cancer	0.00274	0.00356	CcSEcCtD
Acetazolamide—Shock—Sunitinib—pancreatic cancer	0.00271	0.00351	CcSEcCtD
Acetazolamide—Thrombocytopenia—Sunitinib—pancreatic cancer	0.0027	0.0035	CcSEcCtD
Acetazolamide—Melaena—Doxorubicin—pancreatic cancer	0.00268	0.00347	CcSEcCtD
Acetazolamide—Ill-defined disorder—Irinotecan—pancreatic cancer	0.00258	0.00334	CcSEcCtD
Acetazolamide—Aplastic anaemia—Doxorubicin—pancreatic cancer	0.00257	0.00334	CcSEcCtD
Acetazolamide—Urticaria—Tamoxifen—pancreatic cancer	0.00255	0.00331	CcSEcCtD
Acetazolamide—Body temperature increased—Erlotinib—pancreatic cancer	0.00251	0.00326	CcSEcCtD
Acetazolamide—Ill-defined disorder—Gemcitabine—pancreatic cancer	0.00251	0.00326	CcSEcCtD
Acetazolamide—Malaise—Irinotecan—pancreatic cancer	0.00251	0.00325	CcSEcCtD
Acetazolamide—Leukopenia—Irinotecan—pancreatic cancer	0.00249	0.00323	CcSEcCtD
Acetazolamide—CYP3A4—digestive system—pancreatic cancer	0.00248	0.0111	CbGeAlD
Acetazolamide—Paraesthesia—Sunitinib—pancreatic cancer	0.00247	0.00321	CcSEcCtD
Acetazolamide—Hepatic function abnormal—Epirubicin—pancreatic cancer	0.00246	0.00319	CcSEcCtD
Acetazolamide—Photosensitivity—Epirubicin—pancreatic cancer	0.00245	0.00318	CcSEcCtD
Acetazolamide—Malaise—Gemcitabine—pancreatic cancer	0.00244	0.00317	CcSEcCtD
Acetazolamide—Stevens-Johnson syndrome—Docetaxel—pancreatic cancer	0.00244	0.00316	CcSEcCtD
Acetazolamide—Dyspepsia—Sunitinib—pancreatic cancer	0.00242	0.00314	CcSEcCtD
Acetazolamide—Leukopenia—Gemcitabine—pancreatic cancer	0.00242	0.00314	CcSEcCtD
Acetazolamide—Hepatic failure—Epirubicin—pancreatic cancer	0.00239	0.0031	CcSEcCtD
Acetazolamide—Decreased appetite—Sunitinib—pancreatic cancer	0.00239	0.0031	CcSEcCtD
Acetazolamide—Leukopenia—Fluorouracil—pancreatic cancer	0.00238	0.00309	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Sunitinib—pancreatic cancer	0.00238	0.00308	CcSEcCtD
Acetazolamide—Fatigue—Sunitinib—pancreatic cancer	0.00237	0.00308	CcSEcCtD
Acetazolamide—Discomfort—Irinotecan—pancreatic cancer	0.00234	0.00303	CcSEcCtD
Acetazolamide—Hepatobiliary disease—Docetaxel—pancreatic cancer	0.00232	0.00301	CcSEcCtD
Acetazolamide—Asthenia—Tamoxifen—pancreatic cancer	0.00231	0.00299	CcSEcCtD
Acetazolamide—Convulsion—Fluorouracil—pancreatic cancer	0.00231	0.00299	CcSEcCtD
Acetazolamide—Agranulocytosis—Docetaxel—pancreatic cancer	0.00229	0.00297	CcSEcCtD
Acetazolamide—Confusional state—Irinotecan—pancreatic cancer	0.00229	0.00297	CcSEcCtD
Acetazolamide—Asthenia—Erlotinib—pancreatic cancer	0.00228	0.00296	CcSEcCtD
Acetazolamide—Hepatic function abnormal—Doxorubicin—pancreatic cancer	0.00228	0.00295	CcSEcCtD
Acetazolamide—Discomfort—Gemcitabine—pancreatic cancer	0.00228	0.00295	CcSEcCtD
Acetazolamide—Anaphylactic shock—Irinotecan—pancreatic cancer	0.00227	0.00294	CcSEcCtD
Acetazolamide—Photosensitivity—Doxorubicin—pancreatic cancer	0.00227	0.00294	CcSEcCtD
Acetazolamide—Discomfort—Fluorouracil—pancreatic cancer	0.00224	0.0029	CcSEcCtD
Acetazolamide—Shock—Irinotecan—pancreatic cancer	0.00223	0.00289	CcSEcCtD
Acetazolamide—Anaphylactoid reaction—Epirubicin—pancreatic cancer	0.00222	0.00288	CcSEcCtD
Acetazolamide—Thrombocytopenia—Irinotecan—pancreatic cancer	0.00222	0.00288	CcSEcCtD
Acetazolamide—Hepatic failure—Doxorubicin—pancreatic cancer	0.00221	0.00287	CcSEcCtD
Acetazolamide—Anaphylactic shock—Gemcitabine—pancreatic cancer	0.00221	0.00286	CcSEcCtD
Acetazolamide—Hypoglycaemia—Epirubicin—pancreatic cancer	0.0022	0.00286	CcSEcCtD
Acetazolamide—Diarrhoea—Tamoxifen—pancreatic cancer	0.0022	0.00285	CcSEcCtD
Acetazolamide—Hypoaesthesia—Docetaxel—pancreatic cancer	0.0022	0.00285	CcSEcCtD
Acetazolamide—Confusional state—Fluorouracil—pancreatic cancer	0.00219	0.00284	CcSEcCtD
Acetazolamide—Body temperature increased—Sunitinib—pancreatic cancer	0.00218	0.00282	CcSEcCtD
Acetazolamide—Diarrhoea—Erlotinib—pancreatic cancer	0.00218	0.00282	CcSEcCtD
Acetazolamide—Anaphylactic shock—Fluorouracil—pancreatic cancer	0.00217	0.00282	CcSEcCtD
Acetazolamide—Thrombocytopenia—Gemcitabine—pancreatic cancer	0.00216	0.0028	CcSEcCtD
Acetazolamide—Hyponatraemia—Epirubicin—pancreatic cancer	0.00216	0.0028	CcSEcCtD
Acetazolamide—Thrombocytopenia—Fluorouracil—pancreatic cancer	0.00213	0.00276	CcSEcCtD
Acetazolamide—Dizziness—Tamoxifen—pancreatic cancer	0.00213	0.00276	CcSEcCtD
Acetazolamide—Dizziness—Erlotinib—pancreatic cancer	0.0021	0.00273	CcSEcCtD
Acetazolamide—Erythema multiforme—Docetaxel—pancreatic cancer	0.00209	0.00271	CcSEcCtD
Acetazolamide—Anaphylactoid reaction—Doxorubicin—pancreatic cancer	0.00206	0.00267	CcSEcCtD
Acetazolamide—Flushing—Docetaxel—pancreatic cancer	0.00205	0.00266	CcSEcCtD
Acetazolamide—Vomiting—Tamoxifen—pancreatic cancer	0.00204	0.00265	CcSEcCtD
Acetazolamide—Hypoglycaemia—Doxorubicin—pancreatic cancer	0.00204	0.00265	CcSEcCtD
Acetazolamide—Paraesthesia—Irinotecan—pancreatic cancer	0.00204	0.00264	CcSEcCtD
Acetazolamide—Ataxia—Epirubicin—pancreatic cancer	0.00202	0.00262	CcSEcCtD
Acetazolamide—Vomiting—Erlotinib—pancreatic cancer	0.00202	0.00262	CcSEcCtD
Acetazolamide—Somnolence—Irinotecan—pancreatic cancer	0.00202	0.00261	CcSEcCtD
Acetazolamide—Headache—Tamoxifen—pancreatic cancer	0.00201	0.00261	CcSEcCtD
Acetazolamide—Hyponatraemia—Doxorubicin—pancreatic cancer	0.002	0.00259	CcSEcCtD
Acetazolamide—Dyspepsia—Irinotecan—pancreatic cancer	0.002	0.00259	CcSEcCtD
Acetazolamide—Headache—Erlotinib—pancreatic cancer	0.00199	0.00258	CcSEcCtD
Acetazolamide—Paraesthesia—Gemcitabine—pancreatic cancer	0.00198	0.00257	CcSEcCtD
Acetazolamide—Asthenia—Sunitinib—pancreatic cancer	0.00198	0.00256	CcSEcCtD
Acetazolamide—Decreased appetite—Irinotecan—pancreatic cancer	0.00197	0.00256	CcSEcCtD
Acetazolamide—Somnolence—Gemcitabine—pancreatic cancer	0.00196	0.00255	CcSEcCtD
Acetazolamide—Hypokalaemia—Epirubicin—pancreatic cancer	0.00196	0.00254	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.00196	0.00254	CcSEcCtD
Acetazolamide—Fatigue—Irinotecan—pancreatic cancer	0.00196	0.00254	CcSEcCtD
Acetazolamide—Paraesthesia—Fluorouracil—pancreatic cancer	0.00195	0.00253	CcSEcCtD
Acetazolamide—Toxic epidermal necrolysis—Epirubicin—pancreatic cancer	0.00194	0.00251	CcSEcCtD
Acetazolamide—Somnolence—Fluorouracil—pancreatic cancer	0.00193	0.0025	CcSEcCtD
Acetazolamide—Decreased appetite—Gemcitabine—pancreatic cancer	0.00192	0.00249	CcSEcCtD
Acetazolamide—Dyspepsia—Fluorouracil—pancreatic cancer	0.00191	0.00248	CcSEcCtD
Acetazolamide—Nausea—Tamoxifen—pancreatic cancer	0.00191	0.00248	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.00191	0.00247	CcSEcCtD
Acetazolamide—Fatigue—Gemcitabine—pancreatic cancer	0.0019	0.00247	CcSEcCtD
Acetazolamide—Nausea—Erlotinib—pancreatic cancer	0.00189	0.00245	CcSEcCtD
Acetazolamide—Decreased appetite—Fluorouracil—pancreatic cancer	0.00189	0.00245	CcSEcCtD
Acetazolamide—Diarrhoea—Sunitinib—pancreatic cancer	0.00188	0.00244	CcSEcCtD
Acetazolamide—Dysgeusia—Docetaxel—pancreatic cancer	0.00188	0.00244	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.00188	0.00243	CcSEcCtD
Acetazolamide—Ataxia—Doxorubicin—pancreatic cancer	0.00187	0.00243	CcSEcCtD
Acetazolamide—Feeling abnormal—Irinotecan—pancreatic cancer	0.00187	0.00242	CcSEcCtD
Acetazolamide—Dizziness—Sunitinib—pancreatic cancer	0.00182	0.00236	CcSEcCtD
Acetazolamide—Feeling abnormal—Gemcitabine—pancreatic cancer	0.00182	0.00236	CcSEcCtD
Acetazolamide—Hypokalaemia—Doxorubicin—pancreatic cancer	0.00181	0.00235	CcSEcCtD
Acetazolamide—Body temperature increased—Irinotecan—pancreatic cancer	0.00179	0.00232	CcSEcCtD
Acetazolamide—Toxic epidermal necrolysis—Doxorubicin—pancreatic cancer	0.00179	0.00232	CcSEcCtD
Acetazolamide—Feeling abnormal—Fluorouracil—pancreatic cancer	0.00179	0.00232	CcSEcCtD
Acetazolamide—Vomiting—Sunitinib—pancreatic cancer	0.00175	0.00227	CcSEcCtD
Acetazolamide—Body temperature increased—Gemcitabine—pancreatic cancer	0.00175	0.00226	CcSEcCtD
Acetazolamide—Urticaria—Fluorouracil—pancreatic cancer	0.00173	0.00224	CcSEcCtD
Acetazolamide—Headache—Sunitinib—pancreatic cancer	0.00172	0.00224	CcSEcCtD
Acetazolamide—Leukopenia—Docetaxel—pancreatic cancer	0.00172	0.00223	CcSEcCtD
Acetazolamide—Body temperature increased—Fluorouracil—pancreatic cancer	0.00172	0.00223	CcSEcCtD
Acetazolamide—Photosensitivity reaction—Epirubicin—pancreatic cancer	0.0017	0.0022	CcSEcCtD
Acetazolamide—Convulsion—Docetaxel—pancreatic cancer	0.00166	0.00216	CcSEcCtD
Acetazolamide—Drowsiness—Epirubicin—pancreatic cancer	0.00166	0.00215	CcSEcCtD
Acetazolamide—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	0.00164	0.00213	CcSEcCtD
Acetazolamide—Nausea—Sunitinib—pancreatic cancer	0.00164	0.00212	CcSEcCtD
Acetazolamide—Asthenia—Irinotecan—pancreatic cancer	0.00163	0.00211	CcSEcCtD
Acetazolamide—Asthenia—Gemcitabine—pancreatic cancer	0.00158	0.00206	CcSEcCtD
Acetazolamide—Haematuria—Epirubicin—pancreatic cancer	0.00158	0.00205	CcSEcCtD
Acetazolamide—Confusional state—Docetaxel—pancreatic cancer	0.00158	0.00205	CcSEcCtD
Acetazolamide—Photosensitivity reaction—Doxorubicin—pancreatic cancer	0.00157	0.00204	CcSEcCtD
Acetazolamide—Hepatobiliary disease—Epirubicin—pancreatic cancer	0.00157	0.00203	CcSEcCtD
Acetazolamide—Anaphylactic shock—Docetaxel—pancreatic cancer	0.00157	0.00203	CcSEcCtD
Acetazolamide—Diarrhoea—Irinotecan—pancreatic cancer	0.00155	0.00201	CcSEcCtD
Acetazolamide—Agranulocytosis—Epirubicin—pancreatic cancer	0.00155	0.00201	CcSEcCtD
Acetazolamide—Shock—Docetaxel—pancreatic cancer	0.00154	0.002	CcSEcCtD
Acetazolamide—Thrombocytopenia—Docetaxel—pancreatic cancer	0.00153	0.00199	CcSEcCtD
Acetazolamide—Drowsiness—Doxorubicin—pancreatic cancer	0.00153	0.00199	CcSEcCtD
Acetazolamide—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.00152	0.00197	CcSEcCtD
Acetazolamide—Diarrhoea—Gemcitabine—pancreatic cancer	0.00151	0.00196	CcSEcCtD
Acetazolamide—Dizziness—Irinotecan—pancreatic cancer	0.0015	0.00194	CcSEcCtD
Acetazolamide—Diarrhoea—Fluorouracil—pancreatic cancer	0.00149	0.00193	CcSEcCtD
Acetazolamide—Hypoaesthesia—Epirubicin—pancreatic cancer	0.00148	0.00192	CcSEcCtD
Acetazolamide—Haematuria—Doxorubicin—pancreatic cancer	0.00146	0.0019	CcSEcCtD
Acetazolamide—Hepatobiliary disease—Doxorubicin—pancreatic cancer	0.00145	0.00188	CcSEcCtD
Acetazolamide—Vomiting—Irinotecan—pancreatic cancer	0.00144	0.00187	CcSEcCtD
Acetazolamide—Dizziness—Fluorouracil—pancreatic cancer	0.00144	0.00186	CcSEcCtD
Acetazolamide—Agranulocytosis—Doxorubicin—pancreatic cancer	0.00143	0.00186	CcSEcCtD
Acetazolamide—Headache—Irinotecan—pancreatic cancer	0.00142	0.00184	CcSEcCtD
Acetazolamide—Paraesthesia—Docetaxel—pancreatic cancer	0.00141	0.00183	CcSEcCtD
Acetazolamide—Erythema multiforme—Epirubicin—pancreatic cancer	0.00141	0.00182	CcSEcCtD
Acetazolamide—Vomiting—Gemcitabine—pancreatic cancer	0.0014	0.00182	CcSEcCtD
Acetazolamide—Somnolence—Docetaxel—pancreatic cancer	0.00139	0.00181	CcSEcCtD
Acetazolamide—Tinnitus—Epirubicin—pancreatic cancer	0.00139	0.0018	CcSEcCtD
Acetazolamide—Headache—Gemcitabine—pancreatic cancer	0.00138	0.00179	CcSEcCtD
Acetazolamide—Flushing—Epirubicin—pancreatic cancer	0.00138	0.00179	CcSEcCtD
Acetazolamide—Vomiting—Fluorouracil—pancreatic cancer	0.00138	0.00179	CcSEcCtD
Acetazolamide—Dyspepsia—Docetaxel—pancreatic cancer	0.00138	0.00179	CcSEcCtD
Acetazolamide—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.00137	0.00178	CcSEcCtD
Acetazolamide—Decreased appetite—Docetaxel—pancreatic cancer	0.00136	0.00177	CcSEcCtD
Acetazolamide—Headache—Fluorouracil—pancreatic cancer	0.00136	0.00176	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.00135	0.00176	CcSEcCtD
Acetazolamide—Fatigue—Docetaxel—pancreatic cancer	0.00135	0.00175	CcSEcCtD
Acetazolamide—Nausea—Irinotecan—pancreatic cancer	0.00135	0.00175	CcSEcCtD
Acetazolamide—Nausea—Gemcitabine—pancreatic cancer	0.00131	0.0017	CcSEcCtD
Acetazolamide—Erythema multiforme—Doxorubicin—pancreatic cancer	0.0013	0.00169	CcSEcCtD
Acetazolamide—Feeling abnormal—Docetaxel—pancreatic cancer	0.00129	0.00168	CcSEcCtD
Acetazolamide—Nausea—Fluorouracil—pancreatic cancer	0.00129	0.00167	CcSEcCtD
Acetazolamide—Tinnitus—Doxorubicin—pancreatic cancer	0.00128	0.00167	CcSEcCtD
Acetazolamide—Flushing—Doxorubicin—pancreatic cancer	0.00128	0.00166	CcSEcCtD
Acetazolamide—Dysgeusia—Epirubicin—pancreatic cancer	0.00127	0.00165	CcSEcCtD
Acetazolamide—Body temperature increased—Docetaxel—pancreatic cancer	0.00124	0.00161	CcSEcCtD
Acetazolamide—Ill-defined disorder—Epirubicin—pancreatic cancer	0.0012	0.00156	CcSEcCtD
Acetazolamide—Agitation—Epirubicin—pancreatic cancer	0.00119	0.00154	CcSEcCtD
Acetazolamide—Dysgeusia—Doxorubicin—pancreatic cancer	0.00117	0.00152	CcSEcCtD
Acetazolamide—Malaise—Epirubicin—pancreatic cancer	0.00117	0.00152	CcSEcCtD
Acetazolamide—Leukopenia—Epirubicin—pancreatic cancer	0.00116	0.0015	CcSEcCtD
Acetazolamide—Asthenia—Docetaxel—pancreatic cancer	0.00112	0.00146	CcSEcCtD
Acetazolamide—Convulsion—Epirubicin—pancreatic cancer	0.00112	0.00146	CcSEcCtD
Acetazolamide—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.00111	0.00144	CcSEcCtD
Acetazolamide—Agitation—Doxorubicin—pancreatic cancer	0.0011	0.00143	CcSEcCtD
Acetazolamide—Discomfort—Epirubicin—pancreatic cancer	0.00109	0.00141	CcSEcCtD
Acetazolamide—Malaise—Doxorubicin—pancreatic cancer	0.00108	0.0014	CcSEcCtD
Acetazolamide—Leukopenia—Doxorubicin—pancreatic cancer	0.00107	0.00139	CcSEcCtD
Acetazolamide—Diarrhoea—Docetaxel—pancreatic cancer	0.00107	0.00139	CcSEcCtD
Acetazolamide—Confusional state—Epirubicin—pancreatic cancer	0.00107	0.00138	CcSEcCtD
Acetazolamide—Anaphylactic shock—Epirubicin—pancreatic cancer	0.00106	0.00137	CcSEcCtD
Acetazolamide—Shock—Epirubicin—pancreatic cancer	0.00104	0.00135	CcSEcCtD
Acetazolamide—Convulsion—Doxorubicin—pancreatic cancer	0.00104	0.00135	CcSEcCtD
Acetazolamide—Dizziness—Docetaxel—pancreatic cancer	0.00104	0.00134	CcSEcCtD
Acetazolamide—Thrombocytopenia—Epirubicin—pancreatic cancer	0.00104	0.00134	CcSEcCtD
Acetazolamide—Discomfort—Doxorubicin—pancreatic cancer	0.00101	0.00131	CcSEcCtD
Acetazolamide—Vomiting—Docetaxel—pancreatic cancer	0.000997	0.00129	CcSEcCtD
Acetazolamide—Confusional state—Doxorubicin—pancreatic cancer	0.000986	0.00128	CcSEcCtD
Acetazolamide—Headache—Docetaxel—pancreatic cancer	0.000982	0.00127	CcSEcCtD
Acetazolamide—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000978	0.00127	CcSEcCtD
Acetazolamide—Shock—Doxorubicin—pancreatic cancer	0.000962	0.00125	CcSEcCtD
Acetazolamide—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000958	0.00124	CcSEcCtD
Acetazolamide—Paraesthesia—Epirubicin—pancreatic cancer	0.000949	0.00123	CcSEcCtD
Acetazolamide—Somnolence—Epirubicin—pancreatic cancer	0.00094	0.00122	CcSEcCtD
Acetazolamide—Nausea—Docetaxel—pancreatic cancer	0.000931	0.00121	CcSEcCtD
Acetazolamide—Dyspepsia—Epirubicin—pancreatic cancer	0.000931	0.00121	CcSEcCtD
Acetazolamide—Decreased appetite—Epirubicin—pancreatic cancer	0.000919	0.00119	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000913	0.00118	CcSEcCtD
Acetazolamide—Fatigue—Epirubicin—pancreatic cancer	0.000912	0.00118	CcSEcCtD
Acetazolamide—Paraesthesia—Doxorubicin—pancreatic cancer	0.000878	0.00114	CcSEcCtD
Acetazolamide—Feeling abnormal—Epirubicin—pancreatic cancer	0.000871	0.00113	CcSEcCtD
Acetazolamide—Somnolence—Doxorubicin—pancreatic cancer	0.00087	0.00113	CcSEcCtD
Acetazolamide—Dyspepsia—Doxorubicin—pancreatic cancer	0.000861	0.00112	CcSEcCtD
Acetazolamide—Decreased appetite—Doxorubicin—pancreatic cancer	0.00085	0.0011	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000845	0.0011	CcSEcCtD
Acetazolamide—Fatigue—Doxorubicin—pancreatic cancer	0.000843	0.00109	CcSEcCtD
Acetazolamide—Urticaria—Epirubicin—pancreatic cancer	0.00084	0.00109	CcSEcCtD
Acetazolamide—Body temperature increased—Epirubicin—pancreatic cancer	0.000836	0.00108	CcSEcCtD
Acetazolamide—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000806	0.00105	CcSEcCtD
Acetazolamide—Urticaria—Doxorubicin—pancreatic cancer	0.000777	0.00101	CcSEcCtD
Acetazolamide—Body temperature increased—Doxorubicin—pancreatic cancer	0.000773	0.001	CcSEcCtD
Acetazolamide—Asthenia—Epirubicin—pancreatic cancer	0.000759	0.000984	CcSEcCtD
Acetazolamide—Diarrhoea—Epirubicin—pancreatic cancer	0.000723	0.000938	CcSEcCtD
Acetazolamide—Asthenia—Doxorubicin—pancreatic cancer	0.000702	0.00091	CcSEcCtD
Acetazolamide—Dizziness—Epirubicin—pancreatic cancer	0.000699	0.000907	CcSEcCtD
Acetazolamide—Vomiting—Epirubicin—pancreatic cancer	0.000672	0.000872	CcSEcCtD
Acetazolamide—Diarrhoea—Doxorubicin—pancreatic cancer	0.000669	0.000868	CcSEcCtD
Acetazolamide—Headache—Epirubicin—pancreatic cancer	0.000662	0.000859	CcSEcCtD
Acetazolamide—Dizziness—Doxorubicin—pancreatic cancer	0.000647	0.000839	CcSEcCtD
Acetazolamide—Nausea—Epirubicin—pancreatic cancer	0.000628	0.000814	CcSEcCtD
Acetazolamide—Vomiting—Doxorubicin—pancreatic cancer	0.000622	0.000807	CcSEcCtD
Acetazolamide—Headache—Doxorubicin—pancreatic cancer	0.000613	0.000795	CcSEcCtD
Acetazolamide—Nausea—Doxorubicin—pancreatic cancer	0.000581	0.000754	CcSEcCtD
Acetazolamide—CA3—Metabolism—GLP1R—pancreatic cancer	2.32e-05	0.00486	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—DPYD—pancreatic cancer	2.28e-05	0.00479	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—PRSS1—pancreatic cancer	2.23e-05	0.00467	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—PRSS1—pancreatic cancer	2.23e-05	0.00467	CbGpPWpGaD
Acetazolamide—CA1—C-MYB transcription factor network—MYC—pancreatic cancer	2.17e-05	0.00455	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—SLC2A2—pancreatic cancer	2.17e-05	0.00454	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—ARG2—pancreatic cancer	2.12e-05	0.00445	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—ARG2—pancreatic cancer	2.07e-05	0.00434	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—ARG2—pancreatic cancer	2.07e-05	0.00434	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—PRSS1—pancreatic cancer	2.06e-05	0.00433	CbGpPWpGaD
Acetazolamide—CA1—C-MYB transcription factor network—KRAS—pancreatic cancer	2.01e-05	0.0042	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—CD44—pancreatic cancer	1.94e-05	0.00406	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—ARG2—pancreatic cancer	1.93e-05	0.00405	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—ARG2—pancreatic cancer	1.93e-05	0.00405	CbGpPWpGaD
Acetazolamide—SLC22A6—SLC-mediated transmembrane transport—SLC2A2—pancreatic cancer	1.91e-05	0.00401	CbGpPWpGaD
Acetazolamide—CA9—Cellular responses to stress—SOD2—pancreatic cancer	1.88e-05	0.00393	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—GCG—pancreatic cancer	1.86e-05	0.00389	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—TYMP—pancreatic cancer	1.86e-05	0.00389	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—TYMP—pancreatic cancer	1.81e-05	0.00379	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—TYMP—pancreatic cancer	1.81e-05	0.00379	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—ARG2—pancreatic cancer	1.79e-05	0.00375	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—STK11—pancreatic cancer	1.75e-05	0.00366	CbGpPWpGaD
Acetazolamide—CA1—C-MYB transcription factor network—HRAS—pancreatic cancer	1.71e-05	0.00357	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—TYMP—pancreatic cancer	1.69e-05	0.00354	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—TYMP—pancreatic cancer	1.69e-05	0.00354	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—CD44—pancreatic cancer	1.68e-05	0.00352	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—PRSS1—pancreatic cancer	1.65e-05	0.00345	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—GCG—pancreatic cancer	1.61e-05	0.00337	CbGpPWpGaD
Acetazolamide—CA9—HIF-1-alpha transcription factor network—AKT1—pancreatic cancer	1.61e-05	0.00336	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—PRSS1—pancreatic cancer	1.58e-05	0.00331	CbGpPWpGaD
Acetazolamide—CA9—Cellular responses to stress—HIF1A—pancreatic cancer	1.58e-05	0.0033	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—TYMP—pancreatic cancer	1.56e-05	0.00328	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—PRSS1—pancreatic cancer	1.51e-05	0.00317	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—STK11—pancreatic cancer	1.51e-05	0.00317	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—TYMS—pancreatic cancer	1.5e-05	0.00315	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—GLP1R—pancreatic cancer	1.5e-05	0.00313	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—DPYD—pancreatic cancer	1.47e-05	0.00308	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—GLP1R—pancreatic cancer	1.46e-05	0.00306	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—GLP1R—pancreatic cancer	1.46e-05	0.00306	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—DPYD—pancreatic cancer	1.43e-05	0.00301	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—DPYD—pancreatic cancer	1.43e-05	0.00301	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—ARG2—pancreatic cancer	1.43e-05	0.00299	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—SLC2A2—pancreatic cancer	1.4e-05	0.00293	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—ARG2—pancreatic cancer	1.37e-05	0.00287	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—SLC2A2—pancreatic cancer	1.36e-05	0.00285	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—SLC2A2—pancreatic cancer	1.36e-05	0.00285	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—GLP1R—pancreatic cancer	1.36e-05	0.00285	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—GLP1R—pancreatic cancer	1.36e-05	0.00285	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—DPYD—pancreatic cancer	1.34e-05	0.00281	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—DPYD—pancreatic cancer	1.34e-05	0.00281	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—PRSS1—pancreatic cancer	1.33e-05	0.00279	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—ARG2—pancreatic cancer	1.31e-05	0.00275	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—TYMS—pancreatic cancer	1.3e-05	0.00273	CbGpPWpGaD
Acetazolamide—CA9—Cellular responses to stress—RB1—pancreatic cancer	1.28e-05	0.00269	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—SLC2A2—pancreatic cancer	1.27e-05	0.00266	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—SLC2A2—pancreatic cancer	1.27e-05	0.00266	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—GLP1R—pancreatic cancer	1.26e-05	0.00264	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—TYMP—pancreatic cancer	1.25e-05	0.00261	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—DPYD—pancreatic cancer	1.24e-05	0.0026	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—APOE—pancreatic cancer	1.22e-05	0.00256	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—TYMP—pancreatic cancer	1.2e-05	0.00251	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—SLC2A2—pancreatic cancer	1.18e-05	0.00247	CbGpPWpGaD
Acetazolamide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—pancreatic cancer	1.16e-05	0.00243	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—ARG2—pancreatic cancer	1.15e-05	0.00242	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—TYMP—pancreatic cancer	1.15e-05	0.0024	CbGpPWpGaD
Acetazolamide—CA9—Cellular responses to stress—CDKN2A—pancreatic cancer	1.13e-05	0.00236	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—PIK3CG—pancreatic cancer	1.1e-05	0.00231	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—CD44—pancreatic cancer	1.08e-05	0.00227	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—PPARG—pancreatic cancer	1.06e-05	0.00223	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—APOE—pancreatic cancer	1.06e-05	0.00222	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—CD44—pancreatic cancer	1.05e-05	0.00221	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—CD44—pancreatic cancer	1.05e-05	0.00221	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—GCG—pancreatic cancer	1.04e-05	0.00217	CbGpPWpGaD
Acetazolamide—CA9—Cellular responses to stress—CXCL8—pancreatic cancer	1.02e-05	0.00214	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—GCG—pancreatic cancer	1.01e-05	0.00212	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—GCG—pancreatic cancer	1.01e-05	0.00212	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—TYMP—pancreatic cancer	1.01e-05	0.00211	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—GLP1R—pancreatic cancer	1.01e-05	0.00211	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—DPYD—pancreatic cancer	9.9e-06	0.00207	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—CD44—pancreatic cancer	9.84e-06	0.00206	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—CD44—pancreatic cancer	9.84e-06	0.00206	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—STK11—pancreatic cancer	9.75e-06	0.00204	CbGpPWpGaD
Acetazolamide—SLC22A6—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	9.72e-06	0.00204	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—PIK3CD—pancreatic cancer	9.69e-06	0.00203	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—GLP1R—pancreatic cancer	9.64e-06	0.00202	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—PIK3CG—pancreatic cancer	9.56e-06	0.002	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—STK11—pancreatic cancer	9.5e-06	0.00199	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—STK11—pancreatic cancer	9.5e-06	0.00199	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—DPYD—pancreatic cancer	9.49e-06	0.00199	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—GCG—pancreatic cancer	9.44e-06	0.00198	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—GCG—pancreatic cancer	9.44e-06	0.00198	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—SLC2A2—pancreatic cancer	9.39e-06	0.00197	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—GLP1R—pancreatic cancer	9.25e-06	0.00194	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—PPARG—pancreatic cancer	9.22e-06	0.00193	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—CD44—pancreatic cancer	9.12e-06	0.00191	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—DPYD—pancreatic cancer	9.1e-06	0.00191	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—SLC2A2—pancreatic cancer	9e-06	0.00189	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—STK11—pancreatic cancer	8.87e-06	0.00186	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—STK11—pancreatic cancer	8.87e-06	0.00186	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—GCG—pancreatic cancer	8.74e-06	0.00183	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—SLC2A2—pancreatic cancer	8.63e-06	0.00181	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—PIK3CB—pancreatic cancer	8.44e-06	0.00177	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—PIK3CD—pancreatic cancer	8.4e-06	0.00176	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—TYMS—pancreatic cancer	8.39e-06	0.00176	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—PTGS2—pancreatic cancer	8.37e-06	0.00175	CbGpPWpGaD
Acetazolamide—CA9—Cellular responses to stress—VEGFA—pancreatic cancer	8.3e-06	0.00174	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—STK11—pancreatic cancer	8.22e-06	0.00172	CbGpPWpGaD
Acetazolamide—CA9—Cellular responses to stress—STAT3—pancreatic cancer	8.22e-06	0.00172	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—TYMS—pancreatic cancer	8.18e-06	0.00171	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—TYMS—pancreatic cancer	8.18e-06	0.00171	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—GLP1R—pancreatic cancer	8.13e-06	0.0017	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—DPYD—pancreatic cancer	8e-06	0.00168	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—TYMS—pancreatic cancer	7.63e-06	0.0016	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—TYMS—pancreatic cancer	7.63e-06	0.0016	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—SLC2A2—pancreatic cancer	7.59e-06	0.00159	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—PIK3CB—pancreatic cancer	7.32e-06	0.00153	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—PTEN—pancreatic cancer	7.3e-06	0.00153	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—CD44—pancreatic cancer	7.27e-06	0.00152	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—PTGS2—pancreatic cancer	7.26e-06	0.00152	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—TYMS—pancreatic cancer	7.07e-06	0.00148	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—GCG—pancreatic cancer	6.97e-06	0.00146	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—CD44—pancreatic cancer	6.97e-06	0.00146	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—APOE—pancreatic cancer	6.82e-06	0.00143	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—GCG—pancreatic cancer	6.68e-06	0.0014	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—CD44—pancreatic cancer	6.68e-06	0.0014	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—APOE—pancreatic cancer	6.65e-06	0.00139	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—APOE—pancreatic cancer	6.65e-06	0.00139	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—STK11—pancreatic cancer	6.56e-06	0.00137	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—GCG—pancreatic cancer	6.41e-06	0.00134	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—PTEN—pancreatic cancer	6.33e-06	0.00133	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—STK11—pancreatic cancer	6.28e-06	0.00132	CbGpPWpGaD
Acetazolamide—CA9—Cellular responses to stress—TP53—pancreatic cancer	6.27e-06	0.00131	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—APOE—pancreatic cancer	6.21e-06	0.0013	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—APOE—pancreatic cancer	6.21e-06	0.0013	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—PIK3CG—pancreatic cancer	6.16e-06	0.00129	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—STK11—pancreatic cancer	6.03e-06	0.00126	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—PIK3CG—pancreatic cancer	6e-06	0.00126	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—PIK3CG—pancreatic cancer	6e-06	0.00126	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—PPARG—pancreatic cancer	5.94e-06	0.00124	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—CD44—pancreatic cancer	5.88e-06	0.00123	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—PPARG—pancreatic cancer	5.79e-06	0.00121	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—PPARG—pancreatic cancer	5.79e-06	0.00121	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—APOE—pancreatic cancer	5.75e-06	0.0012	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—TYMS—pancreatic cancer	5.64e-06	0.00118	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—GCG—pancreatic cancer	5.63e-06	0.00118	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—PIK3CG—pancreatic cancer	5.6e-06	0.00117	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—PIK3CG—pancreatic cancer	5.6e-06	0.00117	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—PIK3CD—pancreatic cancer	5.41e-06	0.00113	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—PPARG—pancreatic cancer	5.41e-06	0.00113	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—PPARG—pancreatic cancer	5.41e-06	0.00113	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—TYMS—pancreatic cancer	5.41e-06	0.00113	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—STK11—pancreatic cancer	5.3e-06	0.00111	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—PIK3CD—pancreatic cancer	5.28e-06	0.00111	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—PIK3CD—pancreatic cancer	5.28e-06	0.00111	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—PIK3CG—pancreatic cancer	5.19e-06	0.00109	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—TYMS—pancreatic cancer	5.18e-06	0.00109	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—PIK3CA—pancreatic cancer	5.15e-06	0.00108	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—PPARG—pancreatic cancer	5.01e-06	0.00105	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—PIK3CD—pancreatic cancer	4.92e-06	0.00103	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—PIK3CD—pancreatic cancer	4.92e-06	0.00103	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—PIK3CB—pancreatic cancer	4.72e-06	0.000988	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—PTGS2—pancreatic cancer	4.68e-06	0.000979	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—PIK3CB—pancreatic cancer	4.6e-06	0.000963	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—PIK3CB—pancreatic cancer	4.6e-06	0.000963	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—APOE—pancreatic cancer	4.59e-06	0.000961	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—PIK3CD—pancreatic cancer	4.56e-06	0.000956	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—TYMS—pancreatic cancer	4.56e-06	0.000954	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—PTGS2—pancreatic cancer	4.56e-06	0.000954	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—PTGS2—pancreatic cancer	4.56e-06	0.000954	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—PIK3CA—pancreatic cancer	4.46e-06	0.000935	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—APOE—pancreatic cancer	4.4e-06	0.000921	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—PIK3CB—pancreatic cancer	4.29e-06	0.000899	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—PIK3CB—pancreatic cancer	4.29e-06	0.000899	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—PTGS2—pancreatic cancer	4.25e-06	0.000891	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—PTGS2—pancreatic cancer	4.25e-06	0.000891	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—APOE—pancreatic cancer	4.22e-06	0.000883	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—AKT1—pancreatic cancer	4.21e-06	0.000881	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—PIK3CG—pancreatic cancer	4.14e-06	0.000867	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—PTEN—pancreatic cancer	4.08e-06	0.000854	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—PPARG—pancreatic cancer	3.99e-06	0.000837	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—PIK3CB—pancreatic cancer	3.98e-06	0.000833	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—PTEN—pancreatic cancer	3.97e-06	0.000832	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—PTEN—pancreatic cancer	3.97e-06	0.000832	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—PIK3CG—pancreatic cancer	3.97e-06	0.000831	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—PTGS2—pancreatic cancer	3.94e-06	0.000825	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—PPARG—pancreatic cancer	3.83e-06	0.000802	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—PIK3CG—pancreatic cancer	3.8e-06	0.000797	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—PTEN—pancreatic cancer	3.71e-06	0.000777	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—PTEN—pancreatic cancer	3.71e-06	0.000777	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—APOE—pancreatic cancer	3.71e-06	0.000776	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—PPARG—pancreatic cancer	3.67e-06	0.000769	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—AKT1—pancreatic cancer	3.65e-06	0.000764	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—PIK3CD—pancreatic cancer	3.64e-06	0.000762	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—PIK3CD—pancreatic cancer	3.49e-06	0.000731	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—PTEN—pancreatic cancer	3.44e-06	0.00072	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—PIK3CG—pancreatic cancer	3.34e-06	0.000701	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—PIK3CD—pancreatic cancer	3.34e-06	0.000701	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—PPARG—pancreatic cancer	3.23e-06	0.000676	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—PIK3CB—pancreatic cancer	3.17e-06	0.000664	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—PTGS2—pancreatic cancer	3.14e-06	0.000658	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—PIK3CB—pancreatic cancer	3.04e-06	0.000637	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—PTGS2—pancreatic cancer	3.01e-06	0.000631	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—PIK3CD—pancreatic cancer	2.94e-06	0.000616	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—PIK3CB—pancreatic cancer	2.91e-06	0.000611	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—PTGS2—pancreatic cancer	2.89e-06	0.000605	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—PIK3CA—pancreatic cancer	2.88e-06	0.000603	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—PIK3CA—pancreatic cancer	2.8e-06	0.000587	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—PIK3CA—pancreatic cancer	2.8e-06	0.000587	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—PTEN—pancreatic cancer	2.74e-06	0.000574	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—PTEN—pancreatic cancer	2.63e-06	0.00055	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—PIK3CA—pancreatic cancer	2.62e-06	0.000548	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—PIK3CA—pancreatic cancer	2.62e-06	0.000548	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—PIK3CB—pancreatic cancer	2.56e-06	0.000537	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—PTGS2—pancreatic cancer	2.54e-06	0.000532	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—PTEN—pancreatic cancer	2.52e-06	0.000528	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—PIK3CA—pancreatic cancer	2.42e-06	0.000508	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—AKT1—pancreatic cancer	2.35e-06	0.000492	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—AKT1—pancreatic cancer	2.29e-06	0.00048	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—AKT1—pancreatic cancer	2.29e-06	0.00048	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—PRSS1—pancreatic cancer	2.24e-06	0.000469	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—PTEN—pancreatic cancer	2.21e-06	0.000464	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—AKT1—pancreatic cancer	2.14e-06	0.000448	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—AKT1—pancreatic cancer	2.14e-06	0.000448	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—AKT1—pancreatic cancer	1.98e-06	0.000415	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—ARG2—pancreatic cancer	1.94e-06	0.000407	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—PIK3CA—pancreatic cancer	1.93e-06	0.000405	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—PIK3CA—pancreatic cancer	1.85e-06	0.000388	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—PIK3CA—pancreatic cancer	1.78e-06	0.000372	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—TYMP—pancreatic cancer	1.7e-06	0.000356	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—AKT1—pancreatic cancer	1.58e-06	0.000331	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—PIK3CA—pancreatic cancer	1.56e-06	0.000327	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—AKT1—pancreatic cancer	1.51e-06	0.000317	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—AKT1—pancreatic cancer	1.45e-06	0.000304	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—GLP1R—pancreatic cancer	1.37e-06	0.000287	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—DPYD—pancreatic cancer	1.35e-06	0.000282	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	1.28e-06	0.000268	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—AKT1—pancreatic cancer	1.28e-06	0.000267	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—CD44—pancreatic cancer	9.89e-07	0.000207	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—GCG—pancreatic cancer	9.48e-07	0.000199	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—STK11—pancreatic cancer	8.92e-07	0.000187	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—TYMS—pancreatic cancer	7.67e-07	0.000161	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—APOE—pancreatic cancer	6.24e-07	0.000131	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	5.63e-07	0.000118	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—PPARG—pancreatic cancer	5.43e-07	0.000114	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	4.95e-07	0.000104	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	4.31e-07	9.04e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—PTGS2—pancreatic cancer	4.27e-07	8.95e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—PTEN—pancreatic cancer	3.73e-07	7.81e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	2.63e-07	5.51e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—AKT1—pancreatic cancer	2.15e-07	4.5e-05	CbGpPWpGaD
